ctrl K

Watchlist Price Alert

Oruka Therapeutics Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

12.01

-0.42 (-3.38%)

At close: Jun 17, 2025, 3:59 PM

12.56

4.58%

After-hours: Jun 17, 2025, 05:28 PM EDT

Oruka Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	32K	35K	42K	72K	101K	111K	88K	58K	29K
Gross Profit	-32K	-35K	-42K	-72K	-101K	-111K	-88K	-58K	-29K
Operating Income	-84.85M	-62.25M	-33.52M	-6.01M	-7.98M	-7.3M	-5.71M	-3.77M	-1.8M
Interest Income	9.95M	6.34M	2.3M	1.49M	1.98M	1.96M	1.46M	943K	450K
Pretax Income	-75.4M	-56.41M	-31.72M	-4.52M	-6M	-5.34M	-4.25M	-2.83M	-1.35M
Net Income	-75.4M	-56.41M	-31.72M	-4.52M	-6M	-5.34M	-4.25M	-2.83M	-1.35M
Selling & General & Admin	13.7M	10.86M	7.58M	5.4M	7.09M	6.17M	4.65M	3.07M	1.38M
Research & Development	71.12M	51.36M	25.9M	534K	788K	1.01M	966K	644K	390K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	84.82M	62.21M	33.48M	5.94M	7.88M	7.18M	5.62M	3.71M	1.77M
Interest Expense	504K	504K	504K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	34.68M	62.25M	33.52M	6.01M	7.98M	7.3M	5.71M	3.77M	1.8M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	41.68M	16.79M	15.01M	1.21M	1.21M	1.21M	1.2M	1.2M	1.2M
Shares Outstanding (Diluted)	41.68M	16.79M	15.01M	1.21M	1.21M	1.21M	1.2M	1.2M	1.2M
EPS (Basic)	-4.71	-5.87	-5.23	-4.51	-4.98	-4.44	-3.54	-2.35	-1.12
EPS (Diluted)	-4.71	-5.87	-5.23	-4.51	-4.98	-4.44	-3.54	-2.35	-1.12
EBITDA	-74.87M	-55.87M	-31.18M	-4.45M	-5.9M	-5.23M	-4.16M	-2.77M	-1.32M
EBIT	-74.9M	-55.91M	-31.22M	-4.52M	-6M	-5.34M	-4.25M	-2.83M	-1.35M
Depreciation & Amortization	32K	35K	42K	72K	101K	111K	88K	58K	29K